Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A BrownBoris P KovatchevDan RaghinaruJohn W LumBruce A BuckinghamYogish C KudvaLori M LaffelCarol J LevyJordan E PinskerR Paul WadwaEyal DassauFrancis J DoyleStacey M AndersonMei Mei ChurchVikash DadlaniLaya EkhlaspourGregory P ForlenzaElvira IsganaitisDavid W LamCraig KollmanRoy W Becknull nullPublished in: The New England journal of medicine (2019)
In this 6-month trial involving patients with type 1 diabetes, the use of a closed-loop system was associated with a greater percentage of time spent in a target glycemic range than the use of a sensor-augmented insulin pump. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases; iDCL ClinicalTrials.gov number, NCT03563313.).